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Abstract  
BACKGROUND: Adipokines provides new insights about the physiology, pathology and treatment 
of obesity.  
AIM: We investigated the association between serum vaspin and serum visfatin concentrations with 
obesity in Egyptian children.  
MATERIAL AND METHODS: Twenty two obese children with body mass index (BMI) above 95th 
percentile; 11 males and 11 females were included in this study. Their mean age was 9.18 ± 2.8 
years. After general clinical examination, fasting blood glucose, triglycerides, total cholesterol and 
high density lipoprotein cholesterol were measured in cases and controls (n=11). Fasting insulin, 
vaspin and visfatin were detected using ELIZA. Insulin resistance was estimated by Homeostasis 
model assessment method (HOMA-IR).  
RESULTS: Blood pressure, in both systolic and diastolic measurements was elevated significantly 
in obese children. Significant elevation of serum insulin and insulin resistance (HOMA/IR) were 
observed in obese children too. Vaspin and visfatin showed significant elevation in obese children 
than controls. Significant positive correlations were detected between visfatin and BMI, waist 
circumference, hip circumference and HOMA/IR. We found that Vaspin and visfatin are higher in 
obese children. 
CONCLUSION: Visfatin but not vaspin correlates positively with waist circumference and HOMA/IR 
in obese children. 
 
 
Introduction 
Adipose tissue is the source of adipokines, 
secreted mainly by adipocytes. The rapidly growing 
list of adipokines provides new insights about the 
physiology, pathology and treatment of obesity [1]. 
Recently, vaspin (visceral adipose tissue-derived 
serpin protease inhibitor) and visfatin (also known as 
pre-B-cell colony-enhancing factor 1), have been 
identified as interesting novel adipokines having 
insulin-sensitizing and insulin-mimic effects, 
respectively [2].  
Vaspin was originally identified in an animal 
model of obesity and type 2 diabetes. Increased 
vaspin mRNA expression in human adipose tissue 
was found to be associated with obesity [3]. Visfatin, 
in human, is expressed more in visceral adipose 
tissue than subcutaneous one. It is upregulated during 
inflammation [4]. Obesity and metabolic syndrome in 
children and adolescents is a leading cause of a low 
grade systemic inflammation [5]. 
Obesity is associated with an array of health 
problems in adult and pediatric populations.  
Adipokines are signaling to organs such as brain, 
liver, skeletal muscle, and the immune system—
thereby modulating homeostasis, blood pressure, lipid 
and glucose metabolism, inflammation, and 
atherosclerosis [6]. The secretion of several 
adipokines is altered in subjects with abdominal 
adiposity and these changes to the endocrine balance 
may contribute to increased cardiovascular diseases 
risk [7]. The association of novel adipokines, vaspin 
and visfatin, with atherosclerosis is still obscure [8]. 
We investigated the association between 
serum vaspin and serum visfatin concentrations and 
obesity in Egyptian children. 
 
Basic Science 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
  564                                                                                                                                                                                                                     http://www.mjms.mk/ 
http://www.id-press.eu/mjms/ 
 
Subjects and Methods 
 
Subjects 
Twenty two obese children with body mass 
index ((BMI) above 95
th
 percentile 11 males and 11 
females were included in this study. Their mean age 
was 9.18 ± 2.8.  Subjects are free from any other 
diseases. Genetic or endocrine causes of obesity 
were excluded from this study. Cases were not in 
body weight control regime or exercise at the time of 
the study. Eleven age and sex matched children were 
also included and served as controls. All controls had 
normal BMI ranging from 5
th
 to 85
th 
[9]. In this study 
BMI detected according to the Egyptian growth charts 
2002 [10]. All obese and controls children underwent 
thorough medical examination and anthropometric 
measurements by one member of our team works. 
Informed consents were taken from the parents of all 
children included in this study. 
 
Methods 
After 12 hours of fasting a blood sample was 
taken, and the serum was collected. Blood glucose 
level was determined immediately and rest of serum 
was stored at -80°C. Fasting blood glucose, 
triglycerides, total cholesterol and high density 
lipoprotein cholesterol were carried out using an auto 
analyzer (Olympus- Au-400). Low density lipoprotein 
cholesterol was calculated following Friedwald formula 
[11]. Fasting serum insulin was estimated by ELISA 
technique using monobind. Inc, Lack Forest, CA 
(92630) USA.PR. CODE: 2425.300A. Insulin 
resistance estimate by Homeostasis model 
assessment method [HOMA-IR] = [Fasting insulin 
(µu/ml) × Fasting glucose (mmol/litre) / 22.5 [12]. 
Fasting serum visfatin was assessed using ELISA 
using kits from CUSABIO BIOTECH CO., LTD. 
Catalogue No.CSB-EO8940h. Vaspin was assessed 
also by ELISA technique, using kit Human soluble 
Cluster of differentiation 100 (sCD100) ELISA kit from 
CUSABIO BIOTECH CO., LTD. 
 
Statistical Analysis 
Mann-Whitney test was used for not normally 
distributed data and Student's t tests were used for 
normally distributed data. Both tests are performed 
using the statistical version 10 programs (Stat 
Software Inc., Tulsa, OK, USA). The relative strength 
of correlations was calculated using the Spearman 
rank correlation coefficient (rs). 
 
 
Results 
Table 1 showed the descriptive data and 
anthropometric measurements of cases and control 
group. As expected, significant differences were 
detected between cases and controls concerning the 
anthropometric measurements related to obesity. 
Systolic and diastolic blood pressures were 
significantly elevated in obese children. 
Table 1: Demographic and Clinical Data of Obese and Control 
Children. 
P–value 
Control 
n=11 
Cases 
n=22 
 
NS 8.90 ± 3.28 9.18 ± 2.80 Age (years) 
NS 130.64 ± 20.00 137.89 ± 17.06 Height (cm) 
NS -0.009 ± 1.20 0.87 ± 1.12 Height (SDS) 
P≤0.001 28.82 ± 11.62 63.30 ± 25.60 Weight (kg) 
P≤0.001 -0.37 ± 0.56 5.85 ± 2.16 Weight (SDS) 
P≤0.001 16.31 ± 1.66 31.81 ± 6.93 BMI (kg/m
2
) 
P≤0.001 -0.09 ± 0.89 3.60 ± 0.63 BMI (SDS) 
P≤0.0001 56.64 ± 7.39 94.09 ± 15.33 Waist Circumference (cm) 
P≤0.0001 65.00 ± 7.99 99.14 ± 17.44 Hip Circumference (cm) 
P≤0.001 0.87 ± 0.04 0.95 ± 0.073 Waist/Hip Ratio 
P≤0.01 105.91 ± 9.44 119.55 ± 11.90 SBP (mmHg) 
P≤0.01 65.45 ± 7.57 77.05 ± 10.66 DBP (mmHg) 
SBP, systolic blood pressure; DBP, diastolic blood pressure; NS, non significant. 
 
Vaspin concentration was higher in obese 
children than in controls. Similar difference was also 
elicited for serum visfatin. There was no significant 
difference in fasting blood glucose between the two 
studied groups, while significant elevation of serum 
insulin and insulin resistance (HOMA/IR) was 
observed in obese children relative to controls. Total 
cholesterol and LDL values were elevated in obese 
cases; no significant difference was detected in 
triglycerides and HDL in both groups under study 
(Table 2). 
Table 2: Laboratory Data of Obese and Control Children. 
P–value 
Control children 
n=11 
Obese children 
n=22 
 
NS 91.45 ± 7.43 93.36 ± 10.43 Fasting glucose (mg/dl) 
P≤0.01 9.68 ± 5.70 17.3 ± 5.61 Fasting insulin (mU/L) 
P≤0.01 2.11 ± 1.07 4.06 ± 1.51 HOMA / IR 
P≤0.05 162.36 ± 17.92 194.55 ± 42.14 Total Cholesterol (mg/dl) 
NS 67.45 ± 32.94 79.55 ± 34.21 Total Triglycerides (mg/dl) 
NS 73.18 ± 22.96 62.05 ± 20.80 HDL-C (mg/dl) 
P≤0.01 75.82 ± 23.29 115.91 ± 40.18 LDL-C (mg/dl) 
P≤0.01 0.33 ± 0.07 0.68 ± 0.25 Vaspin (ng/ml) 
P≤0.05 4.33 ± 3.01 9.18 ± 3.04 Visfatin (ng/ml) 
 
HMA/IR = Homeostatic model assessment for insulin resistance; HDL-C=High density 
lipoprotein-cholesterol; LDL-C=Low density lipoprotein-cholesterol. 
 
No correlations was found between serum 
vaspin and different demographic, laboratory and 
clinical studied data in obese children, except for a 
positive correlation between vaspin and waist hip ratio 
(P< 0.01, r = 0.7020). Table 3 shows the correlations 
with visfatin in obese children. Significant positive 
correlations were detected between visfatin level and 
height, weight, BMI, waist circumference, hip 
circumference and HOMA / IR of obese children. 
 
Discussion 
 Obesity is one of the most serious risk factors 
for chronic diseases. It plays a central role in insulin 
resistance and metabolic syndrome [13]. Obese 
children in our study showed significant elevated 
serum insulin and insulin resistance (HOMA/IR) than 
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controls. Obesity in childhood and adolescence is also 
associated with established risk factors for 
cardiovascular diseases and accelerated 
atherosclerotic processes [14]. Total cholesterol and 
LDL levels were elevated in obese cases in this study. 
Accelerated atherosclerotic processes are associated 
with elevated triglyceride and lower HDL [15].
 
We 
detected both changes in obese children but levels 
failed to reach significances in comparison to control 
children. Systolic and diastolic blood pressures were 
significantly higher in obese children. Same changes 
in blood pressure were reported by several authors 
[15, 16]. 
Table 3: Correlations of visfatin level with demographic, 
clinical, and laboratory data in obese children. 
Serum visfatin level  
0.4878* 
-0.0510 
Height 
Ht-SDS 
0.5873** 
-0.0922 
Weight 
Wt-SDS 
0.4912* 
0.2508 
BMI 
BMI-SDS 
0.6140** 
0.5775* 
-0.0333 
Waist circumference 
Hip circumference 
W/H ratio 
-0,0308 Total cholesterol  
0,1418 Total triglycerides  
0,0580 High Density Lipoprotein–cholesterol 
-0,0802 Low Density Lipoprotein–cholesterol 
0,6046** HOMA / IR  
0,3739 Systolic Blood Pressure 
0,3626 Diastolic Blood Pressure 
*Spearman's correlation is significant at the level 0.05;; means (P < 0.05). (**) means (P < 
0.01). 
 
 Cekmez et al in 2011 concluded that large for 
gestational age children had a higher vaspin and 
visfatin levels than those who are appropriate for 
gestational age [17]. Our data in obese children 
showed elevated levels of both vaspin and visfatin. 
Many studies concluded the same elevation of visfatin 
in obese children [18, 19]. Pagno et al., in 2006, found 
that plasma visfatin and its mRNA were significantly 
lower in obese subjects, compared with normal-weight 
controls [20]. Variation in results between studies may 
be related to genetic variations [21]. 
 Administration of vaspin to obese mice 
improves glucose tolerance, insulin sensitivity and 
reduces food intake [22]. Vaspin may have 
antiatherogenic effects through its potential insulin-
sensitizing properties and through its beneficial effects 
on the asymmetric dimethylarginine – endothelial 
nitrous oxide system [23]. It also protects vascular 
endothelial cells against free fatty acid-induced 
apoptosis through a phosphatidylinositol 3-kinase/Akt 
pathway [24]. In our study we did not find correlations 
between vaspin and cardiovascular risk factors, 
except with waist / hip circumference, which is not a 
reliable indicator for abdominal fat in children as waist 
cirumference [25]. Failure to detect such correlations 
may be related to different ages of cases in different 
studies and probably a small sample size.  
Visfatin correlated with waist circumference 
and insulin resistance (HOMA/IR) in our study. Such 
correlation with Insulin resistance was elicited by Araki 
et al., in 2008 [26]. Insulin resistance expressed in 
HOMA/IR is more significantly interrelated with the 
metabolic syndrome components [27]. Waist 
circumference, a proxy measure of abdominal obesity, 
is associated with cardio-metabolic risk factors in 
childhood and adolescence [27]. Similar to 
atherosclerosis, abdominal fat is also one of the 
predictor risk factors of morbidity in obese individuals 
[28]. Adipokines may further contribute to obesity-
atherosclerosis relationships, the full understanding of 
which will require much more researches [29].  
  In conclusion vaspin and visfatin levels 
increased in obese children. Visfatin related positively 
to abdominal fat and insulin resistance in the form of 
HOMA/IR; abdominal fat and insulin resistance are 
important indicators of metabolic syndrome in 
children. Vaspin is not a sensitive indicator of 
abdominal obesity and insulin resistance as visfatin. 
Still more researches are needed to explore its role in 
improving insulin tolerance.  
 
References 
1. Ahima RS, Osei SY. Adipokines in obesity. Front Horm Res. 
2008;36:182-97. 
http://dx.doi.org/10.1159/000115365 
2. El-Mesallamy HO, Kassem DH, El-Demerdash E, Amin AI. 
Vaspin and visfatin/Namptare interesting interrelated adipokines 
playing a role in the pathogenesis of type 2 diabetes mellitus. 
Metabolism. 2011;60(1):63-70. 
http://dx.doi.org/10.1016/j.metabol.2010.04.008 
PMid:20605615 
 
3. Blüher M. Vaspin in obesity and diabetes: pathophysiological 
and clinical significance. Endocrine. 2012;41(2):176-82. 
http://dx.doi.org/10.1007/s12020-011-9572-0 
PMid:22139797 
 
4. Stofkovain A. Cachexia – The Interplay Between the Immune 
System, Brain Control and Metabolism. In: Inflammatory Diseases - 
Immunopathology, Clinical and Pharmacological Bases. Ed by 
Mahin Khatami. InTech, 2012. 
http://dx.doi.org/10.5772/25436 
 
5. Kolsgaard ML, Wangensteen T, Brunborg C, Joner G, Holven 
KB, Halvorsen B, Aukrust P, Tonstad S. Elevated visfatin levels in 
overweight and obese children and adolescents with metabolic 
syndrome. Scand J Clin Lab Invest. 2009;69(8):858-64. 
http://dx.doi.org/10.3109/00365510903348677 
PMid:19929281 
 
6. Rabe K, Lehrke M, Parhofer KG, Broedl UC Adipokines and 
insulin resistance. Mol Med. 2008;14(11-12):741-51 
http://dx.doi.org/10.2119/2008-00058.Rabe 
PMid:19009016 PMCid:PMC2582855 
 
7. DeClercq V, Enns JE, Yeganeh A, Taylor CG, Zahradka P. 
Modulation of cardiovascular function by adipokines. Cardiovasc 
Hematol Disord Drug Targets. 2013;13(1):59-72. 
http://dx.doi.org/10.2174/1871529X11313010007 
PMid:22882074 
 
8. Kadoglou NP, Gkontopoulos A, Kapelouzou A, Fotiadis G, 
Theofilogiannakos EK, Kottas G, Lampropoulos S. Serum levels of 
vaspin and visfatin in patients with coronary artery disease-Kozani 
study. Clin Chim Acta. 2011;412(1-2):48-52. 
http://dx.doi.org/10.1016/j.cca.2010.09.012 
PMid:20850423 
 
9. Centre of disease control and prevention. Use of BMI and weight 
clacification especially for children shows how different children 
from adults. CDC Publications, 2005. 
 
10. Egyptian growth curves:Diabetes endocrine metabolism 
 
Basic Science 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
  566                                                                                                                                                                                                                     http://www.mjms.mk/ 
http://www.id-press.eu/mjms/ 
 
pediatric unit, Cairo University Children Hospital. From 
http://dempuegypt.blogspot.com/. Revised 29/11/2008. 
11. Friedwald WT, Levey RI, Frederickson DS. Estimation of the 
concentration of low- density lipoprotein cholesterol in plasma 
without use of the preparative ultracentrifuge. Clin Chem. 1972;18: 
499- 502. 
 
12. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. 
Homeostasis model assessment is more reliable than the fasting 
glucose/insulin ratio and quantitative insulin sensitivity check index 
for assessing insulin resistance among obese children and 
adolescents. Pediatrics. 2005;115(4):e500-3. 
http://dx.doi.org/10.1542/peds.2004-1921 
PMid:15741351 
 
13. Zaki ME, Mohamed SK, Bahgat KA, Kholoussi SM. Metabolic 
syndrome components in obese Egyptian children. Ann Saudi Med. 
2012; 32(6):603-10. 
PMid:23396024 
 
14. Raj M. Obesity and cardiovascular risk in children and 
adolescents. Indian J Endocrinol Metab. 2012; 16(1):13-9. 
http://dx.doi.org/10.4103/2230-8210.91176 
PMid:22276248 PMCid:PMC3263181 
 
15. Urbina EM, Khoury PR, McCoy CE, Dolan LM, Daniels SR, 
Kimball TR. Triglyceride to HDL-C ratio and increased arterial 
stiffness in children, adolescents, and young adults. Pediatrics. 
2013;131(4):e1082-90. 
http://dx.doi.org/10.1542/peds.2012-1726 
PMid:23460684 PMCid:PMC3608484 
 
16. Yang F, Lv JH, Lei SF, Chen XD, Liu MY, Jian WX, Xu H, Tan 
LJ, Deng FY, Yang YJ, Wang YB, Sun X, Xiao SM, Jiang C, Guo 
YF, Guo JJ, Li YN, Zhu XZ, Papasian CJ, Deng HW. Receiver-
operating characteristic analyses of body mass index, waist 
circumference and waist-to-hip ratio for obesity: Screening in 
young adults in central south of China. Clin Nutr. 2006; 25(6):1030-
9. 
http://dx.doi.org/10.1016/j.clnu.2006.04.009 
PMid:16884832 
 
17. Cekmez F, Canpolat FE, Pirgon O, Çetinkaya M, Aydinoz S, 
Suleymanoglu S, Ipcioglu OM, Sarici SU. Apelin, vaspin, visfatin 
and adiponectin in large for gestational age infants with insulin 
resistance. Cytokine. 2011; 56(2):387-91. 
http://dx.doi.org/10.1016/j.cyto.2011.06.007 
PMid:21742512 
 
18. Davutoglu M, Ozkaya M, Guler E, Garipardic M, Gursoy H, 
Karabiber H, Kilinc M. Plasma visfatin concentrations in childhood 
obesity: relationships with insulin resistance and anthropometric 
indices. Swiss Med Wkly. 2009; 139(1-2):22-7. 
PMid:19142752 
 
19. Taşçilar ME, Cekmez F, Meral C, Pirgon O, Tanju IA, Canpolat 
FE, Abaci A, Tapan S, Eker I. Evaluation of adipocytokines in 
obese children with insulin resistance. Turk J Pediatr. 2011; 
53(3):269-73. 
PMid:21980807 
 
20. Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R, 
Milan G, Rossato M, Federspil G, Vettor R. Reduced plasma 
visfatin/pre-B cell colony-enhancing factor in obesity is not related 
to insulin resistance in humans. J Clin Endocrinol Metab. 2006; 
91(8):3165-70. 
 
http://dx.doi.org/10.1210/jc.2006-0361 
PMid:16720654 
21. Breitfeld J, Tönjes A, Böttcher Y, Schleinitz D, Wiele N, Marzi 
C, Brockhaus C, Rathmann W, Huth C, Grallert H, Illig T, Blüher M, 
Kovacs P, Stumvoll M. Genetic variation in the vaspin gene affects 
circulating serum vaspin concentrations. Int J Obes (Lond). 2012; 
21:133 
 
22. Blüher M. Vaspin in obesity and diabetes: pathophysiological 
and clinical significance. Endocrine. 2012; 41(2):176-82. 
http://dx.doi.org/10.1007/s12020-011-9572-0 
PMid:22139797 
 
23. Chang Hee Jung; Woo Je Lee; Jenie Yoonoo Hwang; Min Jung 
Lee; So Mi Seol; Yun Mi Kim; Yoo La Lee; Hyun Sik Kim; Min-Seon 
Kim; Joong-Yeol Park. Vaspin Increases Nitric Oxide Bioavailability 
through the Reduction of Asymmetric Dimethylarginine in Vascular 
Endothelial Cells. PLoS ONE. 2012;7(12):1. 
http://dx.doi.org/10.1371/journal.pone.0052346 
PMid:23284999 PMCid:PMC3532208 
 
24. Jung CH, Lee WJ, Hwang JY, Seol SM, Kim YM, Lee YL, Park 
JY. Vaspin protects vascular endothelial cells against free fatty 
acid-induced apoptosis through a phosphatidylinositol 3-kinase/Akt 
pathway. Biochem Biophys Res Commun. 2011; 413(2):264-9. 
http://dx.doi.org/10.1016/j.bbrc.2011.08.083 
PMid:21893030 
 
25. Kalker U, Hövels O, Kolbe-Saborowski H. Obese children and 
adolescents. Waist-hip ratio and cardiovascular risk. Monatsschr 
Kinderheilkd. 1993; 141(1):36-41. 
PMid:8446116 
 
26. Araki S, Dobashi K, Kubo K, Kawagoe R, Yamamoto Y, 
Kawada Y, Asayama K, Shirahata A. Plasma visfatin concentration 
as a surrogate marker for visceral fat accumulation in obese 
children. Obesity (Silver Spring). 2008; 16(2):384-8. 
http://dx.doi.org/10.1038/oby.2007.54 
PMid:18239648 
 
27. Sharma S, Lustig RH, Fleming SE. Identifying metabolic 
syndrome in African American children using fasting HOMA-IR in 
place of glucose. Prev Chronic Dis. 2011;8(3):A64. 
PMid:21477504 PMCid:PMC3103569 
 
28. Hatipoglu N, Mazicioglu MM, Poyrazoglu S, Borlu A, Horoz D, 
Kurtoglu S. Waist circumference percentiles among Turkish 
children under the age of 6 years. Eur J Pediatr. 2013;172(1):59-69 
http://dx.doi.org/10.1007/s00431-012-1822-5 
PMid:23015041 PMCid:PMC3543614 
 
29. R A, S H, Ruma D. The waist circumference measurement: a 
simple method for assessing the abdominal obesity. J Clin Diagn 
Res. 2012;6(9):1510-3. 
http://dx.doi.org/10.7860/jcdr/2012/4379.2545 
 
30. Gauvreau D, Villeneuve N, Deshaies Y, Cianflone K. [Novel 
adipokines: links between obesity and atherosclerosis]. Ann 
Endocrinol (Paris). 2011;72(3):224-31. 
http://dx.doi.org/10.1016/j.ando.2010.02.025 
PMid:21592454 
 
 
